Press "Enter" to skip to content

FDA grants priority review to Pfizer/BioNTech Covid-19 vaccine; decision on approval expected by January

Pfizer and BioNTech announced Friday that the US Food and Drug Administration has granted priority review designation to the companies’ application for approval of their Covid-19 vaccine. The goal date for a decision from the FDA is January 2022, the companies said.

Pfizer and BioNTech announced Friday that the US Food and Drug Administration has granted priority review designation to the companies’ application for approval of their Covid-19 vaccine. The goal date for a decision from the FDA is January 2022, the companies said.

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *